Mode
Text Size
Log in / Sign up

Anterior commissure involvement in early glottic carcinoma treated with radiotherapy

Anterior commissure involvement in early glottic carcinoma treated with radiotherapy
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider that anterior commissure involvement may not be a definitive prognostic factor for local recurrence in early glottic carcinoma after radiotherapy.

This is a meta-analysis and review of patients with early-stage glottic carcinoma treated with definitive radiotherapy. The study synthesized evidence on the prognostic impact of anterior commissure involvement (ACI) compared to its absence. The total sample size across included studies was 2527 patients. The setting was not reported in the source data.

The intervention or exposure was the presence of anterior commissure involvement. The comparator was the absence of anterior commissure involvement. Specific radiotherapy dosing or protocol details were not reported in the input. The primary outcome was local failure, defined as local recurrence.

In the primary analysis, the presence of ACI was significantly associated with an increased risk of local recurrence in univariate analysis. The effect size was an odds ratio (OR) of 1.61 (95% CI 1.15-2.26) with a p-value of 0.006. However, in multivariate models, the adjusted ORs ranged from 1.05 to 1.43, and the 95% credible intervals included unity, indicating no consistent significant association. The direction of effect was increased risk in univariate analysis but attenuated and non-significant in multivariate models. Absolute numbers for local recurrence events were not reported.

Key secondary outcomes were not reported in the input data. The review did not provide specific secondary outcome results or data.

Safety and tolerability findings were not reported. The input states that adverse events, serious adverse events, discontinuations, and overall tolerability were not reported. Therefore, no safety data can be presented from this synthesis.

These results can be compared to prior landmark studies in this therapeutic area, but the input does not specify which prior studies were reviewed or their findings. The review notes that the univariate findings may be confounded by correlation with other factors, and the ACI effect was not confirmed in adjusted models. The certainty note indicates that a Bayesian multivariate meta-analysis provided more robust evidence than univariate analysis.

Key methodological limitations include moderate heterogeneity (I^2 = 34%) in the univariate analysis and incomplete reporting of risk factors in some studies. Potential biases may arise from these limitations and the observational nature of the included studies. The causality note clarifies that association versus causation was not explicitly distinguished, and multivariate analysis suggests confounding by other factors, such as T substage.

Clinical implications are that ACI should not be regarded as a fundamental prognostic criterion in early-stage glottic carcinoma, based on this synthesis. Practice decisions should not rely solely on ACI status, given the attenuated effect in adjusted models. What questions remain unanswered include the specific impact of ACI in well-defined subgroups, the interaction with other tumor characteristics, and the need for prospective validation of these findings in controlled settings.

Study Details

Study typeMeta analysis
Sample sizen = 2,527
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Early-stage glottic carcinoma is characterized by high cure rate, but about 10% of patients still develop local recurrence after radiotherapy (RT). Although advances in local therapies have markedly improved larynx preservation, anterior commissure involvement (ACI) may worsen outcomes yet remains insufficient to fully guide personalized treatment. Here, we conducted a univariate meta-analysis and a Bayesian multivariate meta-analysis of multiple factors (MVMA-MF) to evaluate the prognostic impact of ACI and on local failure in early-stage glottic carcinoma. METHODS: We conducted a systematic review with univariate meta-analysis and MVMA-MF using data from studies of early-stage glottic carcinoma treated with definitive RT, incorporating clinical information, risk factors and survival outcomes. A systematic literature search was conducted in PubMed and Scopus on Sep 27, 2025. Eligible studies provided sufficient data to estimate odds ratios (ORs) for local control in relation to patient, tumor and treatment factors, including ACI. Data extraction followed PRISMA guidelines, and study quality was assessed using MINORS criteria. The primary endpoint of the study was the effect of ACI on local failure. Pooled ORs were calculated with a random-effects model, and heterogeneity was assessed using the Cochrane Q test and I statistic. To address correlations among risk factors, we applied a Bayesian multivariate meta-analysis of multiple factors (MVMA-MF), testing three models (H, M0, U) with Markov Chain Monte Carlo algorithm. FINDINGS: Nine clinical trials representing 2527 patients were included. In univariate meta-analysis, the presence of ACI was significantly associated with an increased risk of local recurrence in early-stage glottic carcinoma treated with RT (OR 1.61, 95% CI 1.15-2.26, p = 0.006), with moderate heterogeneity (I  = 34%). In MVMA-MF including 14 risk factors, only T substage demonstrated a consistent and statistically significant association with recurrence across all models. ACI, smoking status and other risk factors showed non-significant associations, with wide credible intervals overlapping unity. Correlation analysis revealed mostly low-to-moderate inter-variable correlations, supporting the multivariable modeling approach. Comparison of univariate and multivariate estimates for ACI indicated that the unadjusted analysis suggested increased recurrence risk, whereas adjusted models yielded attenuated and non-significant associations (adjusted ORs 1.05-1.43, all 95% CrIs including unity). INTERPRETATION: This study represents the first application of both univariate and multivariate meta-analysis to clarify the prognostic role of ACI in early-stage glottic carcinoma treated with definitive RT. While univariate analysis suggested ACI increased recurrence risk, this effect was not confirmed in MVMA-MF, indicating the univariate findings may be confounded by correlation with other factors, particularly T substage. MVMA-MF approach accounted for heterogeneity, collinearity and incomplete reporting, providing more robust evidence. This work underscores the value of advanced multivariate methods in oncology meta-analysis and provides the strongest evidence to date that ACI should not be regarded as a fundamental prognostic criterion in early-stage glottic carcinoma.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.